Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs VNET Group Inc (VNET) Price & Performance

Novartis AGTrade
VNET Group IncTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs VNET Group Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while VNET Group Inc trades at $7.7 (market cap $2.19B). The key difference: Novartis AG is far larger — about 132.5× VNET Group Inc's market cap, and Novartis AG pays a 3.17% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals.

NVSVNET
Market Cap
$290.25B$2.19B
Sector
HealthTechnology
52-Week High
$168.62$14.03
52-Week Low
$113.50$7.34
Enterprise Value
$330.27B$5.32B
Dividend Yield
3.17%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About VNET Group Inc

VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.

Read more on VNET